Literature DB >> 28069496

Probiotic E. coli Nissle 1917 biofilms on silicone substrates for bacterial interference against pathogen colonization.

Quan Chen1, Zhiling Zhu2, Jun Wang2, Analette I Lopez2, Siheng Li2, Amit Kumar2, Fei Yu2, Haoqing Chen2, Chengzhi Cai3, Lijuan Zhang4.   

Abstract

Bacterial interference is an alternative strategy to fight against device-associated bacterial infections. Pursuing this strategy, a non-pathogenic bacterial biofilm is used as a live, protective barrier to fence off pathogen colonization. In this work, biofilms formed by probiotic Escherichia coli strain Nissle 1917 (EcN) are investigated for their potential for long-term bacterial interference against infections associated with silicone-based urinary catheters and indwelling catheters used in the digestive system, such as feeding tubes and voice prostheses. We have shown that EcN can form stable biofilms on silicone substrates, particularly those modified with a biphenyl mannoside derivative. These biofilms greatly reduced the colonization by pathogenic Enterococcus faecalis in Lysogeny broth (LB) for 11days. STATEMENT OF SIGNIFICANCE: Bacterial interference is an alternative strategy to fight against device-associated bacterial infections. Pursuing this strategy, we use non-pathogenic bacteria to form a biofilm that serves as a live, protective barrier against pathogen colonization. Herein, we report the first use of preformed probiotic E. coli Nissle 1917 biofilms on the mannoside-presenting silicone substrates to prevent pathogen colonization. The biofilms serve as a live, protective barrier to fence off the pathogens, whereas current antimicrobial/antifouling coatings are subjected to gradual coverage by the biomass from the rapidly growing pathogens in a high-nutrient environment. It should be noted that E. coli Nissle 1917 is commercially available and has been used in many clinical trials. We also demonstrated that this probiotic strain performed significantly better than the non-commercial, genetically modified E. coli strain that we previously reported.
Copyright © 2017 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Bacterial interference; Biofilms; Catheter-associated urinary tract infection; E. coli Nissle 1917; Mannoside

Mesh:

Substances:

Year:  2017        PMID: 28069496     DOI: 10.1016/j.actbio.2017.01.011

Source DB:  PubMed          Journal:  Acta Biomater        ISSN: 1742-7061            Impact factor:   8.947


  5 in total

Review 1.  The Battle of Probiotics and Their Derivatives Against Biofilms.

Authors:  Abolfazl Barzegari; Keyvan Kheyrolahzadeh; Seyed Mahdi Hosseiniyan Khatibi; Simin Sharifi; Mohammad Yousef Memar; Sepideh Zununi Vahed
Journal:  Infect Drug Resist       Date:  2020-02-26       Impact factor: 4.003

2.  Anti-biofilm potential of Lactobacillus plantarum Y3 culture and its cell-free supernatant against multidrug-resistant uropathogen Escherichia coli U12.

Authors:  Asmaa F Mekky; Wesam A Hassanein; Fifi M Reda; Hanan M Elsayed
Journal:  Saudi J Biol Sci       Date:  2022-01-15       Impact factor: 4.052

3.  Interactions Between Infectious Foodborne Viruses and Bacterial Biofilms Formed on Different Food Contact Surfaces.

Authors:  Marie-Josée Gagné; Tony Savard; Julie Brassard
Journal:  Food Environ Virol       Date:  2022-08-27       Impact factor: 4.034

4.  Functional investigation of the chromosomal ccdAB and hipAB operon in Escherichia coli Nissle 1917.

Authors:  Jun Xu; Kai Xia; Pinyi Li; Chenggong Qian; Yudong Li; Xinle Liang
Journal:  Appl Microbiol Biotechnol       Date:  2020-06-13       Impact factor: 4.813

5.  Using Lactobacilli to Fight Escherichia coli and Staphylococcus aureus Biofilms on Urinary Tract Devices.

Authors:  Fábio M Carvalho; Filipe J M Mergulhão; Luciana C Gomes
Journal:  Antibiotics (Basel)       Date:  2021-12-14
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.